{"organizations": [], "uuid": "86e96477f1735dab8fba5ef270b78f35420af37e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180209.html", "section_title": "Archive News &amp; Video for Friday, 09 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-solasia-pharma-says-termination-of/brief-solasia-pharma-says-termination-of-clinical-trials-phase-1-of-sp-04-idUSL4N1PZ37R", "country": "US", "domain_rank": 408, "title": "BRIEF-Solasia Pharma says termination of clinical trials phase 1 of SP-04", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.462, "site_type": "news", "published": "2018-02-09T16:12:00.000+02:00", "replies_count": 0, "uuid": "86e96477f1735dab8fba5ef270b78f35420af37e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-solasia-pharma-says-termination-of/brief-solasia-pharma-says-termination-of-clinical-trials-phase-1-of-sp-04-idUSL4N1PZ37R", "ord_in_thread": 0, "title": "BRIEF-Solasia Pharma says termination of clinical trials phase 1 of SP-04", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-solasia pharma", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "solasia pharma kk", "sentiment": "negative"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 9 (Reuters) - Solasia Pharma KK\n* Says it announces termination of SP-04 clinical trials phase 1, for treatment of peripheral nerves disability\nSource text in Japanese: goo.gl/inouVL\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/inouVL"], "published": "2018-02-09T16:12:00.000+02:00", "crawled": "2018-02-10T14:17:47.000+02:00", "highlightTitle": ""}